Skip to contentWEAVER GREGORY L — ATOSSA GENETICS INC insider: 115 transactions · InsiderLensWEAVER GREGORY L
- Director at CELSION CORP · on record since Mar 16, 2006
- Senior Vice President and CFO at SIRNA THERAPEUTICS INC · on record since Feb 15, 2006
- Former EVP, CFO, & Director at ATOSSA GENETICS INC · on record since Jun 20, 2023
- Director at SCOLR Pharma, Inc. · on record since Oct 10, 2007
- Chief Financial Officer at NEORX CORP · on record since Feb 19, 2009
- Director at ATOSSA GENETICS INC · on record since Nov 22, 2013
- Chief Financial Officer at NASTECH PHARMACEUTICAL CO INC · on record since Jul 3, 2003
- Chief Financial Officer at AtaiBeckley Inc. · on record since Jun 24, 2021
- Chief Financial Officer at ALTEON INC /DE · on record since Apr 1, 2026
- CFO at CELSION CORP · on record since Mar 21, 2013
- Chief Financial Officer at ISOLAGEN INC · on record since Aug 28, 2013
- Director at Eagle Test Systems, Inc. · on record since Feb 7, 2014
- CHIEF FINANCIAL OFFICER at SENESCO TECHNOLOGIES INC · on record since Jan 31, 2019
- FORMER CHIEF FINANCIAL OFFICER at SENESCO TECHNOLOGIES INC · on record since Mar 16, 2020
Insider trading activity of WEAVER GREGORY L
- Transactions on record
- 115
- since Sep 12, 2003
- Open-market buys
- 18
- $506.5K
- Open-market sells
- 2
- $639.3K
- Companies traded
- 11
- last filing Apr 1, 2026
Figures computed from official regulatory filings — methodology.
Companies where WEAVER GREGORY L has traded
- ALTEON INC /DE12 tx · $125.5K · Apr 1, 2026
- ATOSSA GENETICS INC26 tx · $1.4M · Jun 20, 2023
- AtaiBeckley Inc.3 tx · $70K · Mar 4, 2022
- SENESCO TECHNOLOGIES INC13 tx · $55.2K · Mar 16, 2020
- Eagle Test Systems, Inc.14 tx · $268.5K · Feb 4, 2019
- ISOLAGEN INC3 tx · $35.1K · Jan 21, 2014
- CELSION CORP22 tx · $913.8K · Mar 21, 2013
- NEORX CORP7 tx · $502.3K · Feb 8, 2010
- SCOLR Pharma, Inc.2 tx · Jun 6, 2008
- SIRNA THERAPEUTICS INC
Track record of WEAVER GREGORY L
Statistical track record
Free- Open-market buys
- 19
- Last buy
- Apr 1, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of WEAVER GREGORY L
Co-insiders of WEAVER GREGORY L
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $75.9K · Jan 4, 2007
NOVARTIS AGALTEON INC /DE +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 1, 2026 | Buy | 10,000 | 3.15 USD | $31.5K | SEC |
| Mar 9, 2026 | Buy | 5,000 | 3.54 USD | $17.7K | SEC |
| Feb 27, 2026 | AwardD | 259,000 | 0.00 USD | $0 | SEC |
| Feb 27, 2026 | AwardD | 111,000 | 0.00 USD | $0 | SEC |
| Nov 12, 2025 | Exercise | 18,750 | 0.00 USD | $0 | SEC |
| Nov 12, 2025 | ExerciseD | -18,750 | 0.00 USD | $0 | SEC |
| Nov 12, 2025 | Other | -5,672 | 4.28 USD | $24.3K | SEC |
| Oct 3, 2025 | AwardD | 166,800 | 0.00 USD | $0 | SEC |
| Oct 3, 2025 | AwardD | 57,900 | 0.00 USD | $0 | SEC |
| Mar 14, 2025 | Buy | 10,000 | 5.20 USD | $52K | SEC |
| Nov 12, 2024 | AwardD | 75,000 | 0.00 USD | $0 | SEC |
| Nov 12, 2024 | AwardD | 225,000 | 0.00 USD | $0 | SEC |
| Jun 20, 2023 | Buy | 50,000 | 0.97 USD | $48.5K | SEC |
| Jun 5, 2023 | AwardD | 2,600,000 | 0.00 USD | $0 | SEC |
| May 5, 2023 | AwardD | 125,000 | 0.00 USD | $0 | SEC |
| May 16, 2022 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Mar 4, 2022 | AwardD | 228,000 | 0.00 USD | $0 | SEC |
| Jul 7, 2021 | ExerciseD | -45,000 | 0.00 USD | $0 | SEC |
| Jul 7, 2021 | Other | -57,084 | 6.40 USD | $365.3K | SEC |
| Jul 7, 2021 | Exercise | 45,000 | 2.38 USD | $107.1K | SEC |
| Jul 7, 2021 | Exercise | 45,000 | 2.52 USD | $113.4K | SEC |
| Jul 7, 2021 | ExerciseD | -4,581 | 0.00 USD | $0 | SEC |
| Jul 7, 2021 | Sell | -107,497 | 5.58 USD | $599.8K | SEC |
| Jul 7, 2021 | ExerciseD | -45,000 | 0.00 USD | $0 | SEC |
| Jul 7, 2021 | Exercise | 4,581 | 5.64 USD | $25.8K | SEC |